Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126940361 | 12694036 | 1 | I | 2015 | 20160616 | 20160829 | 20160829 | PER | US-JNJFOC-20160616008 | JANSSEN | 0.00 | A | F | Y | 86.18000 | KG | 20160829 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126940361 | 12694036 | 1 | PS | CONCERTA | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | N | UNKNOWN | 21121 | 54 | MG | SUSTAINED RELEASE TABLETS | QD | |||||
| 126940361 | 12694036 | 2 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | Oral | 0 | 30 | MG | TABLETS | BID | |||||||
| 126940361 | 12694036 | 3 | C | VICTOZA | LIRAGLUTIDE | 1 | Other | 0 | 1.8 | MG | SOLUTION | QD | |||||||
| 126940361 | 12694036 | 4 | C | LAMOTRIGINE. | LAMOTRIGINE | 1 | Oral | 0 | 50 | MG | TABLET | TID | |||||||
| 126940361 | 12694036 | 5 | C | LAMOTRIGINE. | LAMOTRIGINE | 1 | Oral | 0 | 50 | MG | TABLET | TID | |||||||
| 126940361 | 12694036 | 6 | C | LORAZEPAM. | LORAZEPAM | 1 | Oral | ONCE AT NIGHT | 0 | .5 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126940361 | 12694036 | 1 | Attention deficit/hyperactivity disorder |
| 126940361 | 12694036 | 2 | Attention deficit/hyperactivity disorder |
| 126940361 | 12694036 | 3 | Hypoglycaemia |
| 126940361 | 12694036 | 4 | Depression |
| 126940361 | 12694036 | 5 | Anxiety |
| 126940361 | 12694036 | 6 | Anxiety |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126940361 | 12694036 | Drug ineffective | |
| 126940361 | 12694036 | Inappropriate schedule of drug administration | |
| 126940361 | 12694036 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126940361 | 12694036 | 1 | 2015 | 0 | ||
| 126940361 | 12694036 | 2 | 2015 | 0 | ||
| 126940361 | 12694036 | 3 | 2016 | 0 | ||
| 126940361 | 12694036 | 4 | 2015 | 0 | ||
| 126940361 | 12694036 | 5 | 2015 | 0 |